The conference highlighted recent advances in the diagnosis and management of obesity, endocrine disorders, diabetes, and growth hormone and thyroid diseases.
FDA advisers support new Alzheimer’s drug
Jun 11, 2024
A US Food and Drug Administration advisory panel voted unanimously on Monday to recommend that the benefits of a new drug for Alzheimer’s outweigh its harms, which can include brain swelling and...
ACP: Recommendations developed for newer type 2 diabetes medications
Apr 22, 2024
A strong recommendation was given for the addition of an SGLT-2 or GLP-1 agonist to metformin, and lifestyle modifications.
US medical drug shortages reach record high
Apr 15, 2024
Americans are facing more shortages of the drugs they need for medical care than ever before, a national pharmacy database shows.
Biden administration calls for greater access to overdose antidote
Mar 13, 2024
The need for naloxone is great: Overdose deaths spiked 30% between 2019 and 2020 and another 15% between 2020 and 2021.
Many older Americans would like to take fewer meds, poll reveals
Apr 25, 2023
Older Americans think they take too many medicines, and a sizable percentage said they have cut back.
AHA: Semaglutide cuts risk for CVD events in patients without diabetes
Nov 14, 2023
Findings seen over three years in adults with preexisting cardiovascular disease and overweight or obesity
FDA allows Florida to import cheaper drugs from Canada
Jan 05, 2024
The plan would let Florida buy selected drugs in bulk from Canada, following FDA review.
Cyberattack stalls prescription dispensing at UnitedHealth
Feb 27, 2024
This latest cyberattack underscores the vulnerability of healthcare data, particularly the privacy of patients’ personal information.
COVID-19 meds like Paxlovid will soon have big price tags
Oct 30, 2023
The pills still will be available at no cost until those bought earlier by the federal government run out.